Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

REalloys (NASDAQ: ALOY) Appoints Former Chief of Staff to the U.S. Secretary of Defense Joe Kasper as Chair of Its Advisory Board

REalloys (NASDAQ: ALOY) Appoints Former Chief of Staff to the U.S. Secretary of Defense Joe Kasper as Chair of Its Advisory Board

REalloys Inc. has appointed Joe Kasper, former Chief of Staff to the U.S. Secretary of Defense and a supply chain expert, as Chair of its Advisory Board. The appointment bolsters REalloys' strategic defense-focused leadership alongside General Jack Keane and Stephen duMont, emphasizing a sovereign, China-free rare earth supply chain crucial to U.S.…

Gevo Announces it is Developing Plans for Major Ethanol Expansion at Richardton, North Dakota Facility

Gevo Announces it is Developing Plans for Major Ethanol Expansion at Richardton, North Dakota Facility

Gevo, Inc. announced it is planning a significant expansion at its Richardton, North Dakota facility by adding a second ethanol plant with up to 75 million gallons per year capacity of low-carbon ethanol. This expansion, combined with a prior incremental increase, could raise total production to 150 million gallons per year of low-carbon ethanol an…

ServiceTitan Report Finds AI Adoption More Than Doubles Among Commercial Contractors as Firms Turn to Technology to Navigate Cost Pressures

ServiceTitan Report Finds AI Adoption More Than Doubles Among Commercial Contractors as Firms Turn to Technology to Navigate Cost Pressures

ServiceTitan's 2026 industry report highlights a surge in AI adoption among commercial contractors, with 38% now seeing measurable business impact, up from 17% in 2025. Contractors face strong demand but rising labor and material costs, prompting a greater emphasis on profitability, cash flow management, and technology consolidation to improve oper…

Silvaco Announces Strategic Partnership with APEC to Advance Silicon Carbide Power Device Development

Silvaco Announces Strategic Partnership with APEC to Advance Silicon Carbide Power Device Development

Silvaco Group, Inc. announced an expanded strategic partnership with Advanced Power Electronics Corp. (APEC) to leverage Silvaco’s advanced simulation tools including Victory Device, Gateway, and SmartSpice. This collaboration aims to accelerate the development and optimization of APEC’s silicon carbide power devices, impacting industries such as a…

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

Nanobiotix announced the presentation of early Phase 2 clinical trial results from the Johnson & Johnson-sponsored CONVERGE study evaluating the novel nanoradioenhancer JNJ-1900 (NBTXR3) in patients with stage 3 inoperable non-small cell lung cancer. Initial data demonstrate a favorable safety profile and encouraging efficacy signals, including a h…

Uniti Fiber Names Heather Orrico to Lead Enterprise Sales

Uniti Fiber Names Heather Orrico to Lead Enterprise Sales

Uniti Fiber announced the hiring of Heather Orrico as president of Enterprise Sales to enhance its enterprise sales strategy and drive growth in the Southeastern United States. With over 20 years of telecom experience and proven leadership at Comcast, Orrico's expertise is expected to strengthen Uniti Fiber's position in delivering fiber infrastruc…

BiomX Adds Former Mossad Deputy to Advisory Board

BiomX Adds Former Mossad Deputy to Advisory Board

BiomX Inc. appointed Dr. Ehud Levi, former Deputy Director of Mossad, to its Advisory Board to support strategic expansion into security, defense, aerial response, and counter-UAS technologies. Dr. Levi's extensive intelligence and counter-terrorism experience is expected to guide BiomX in exploring new partnerships and business opportunities in de…

AleAnna, Inc. Reports Fourth Quarter and Full Year 2025 Results

AleAnna, Inc. Reports Fourth Quarter and Full Year 2025 Results

AleAnna, Inc. announced its financial and operational results for Q4 and full year 2025, reporting a net income of $2.9 million and adjusted EBITDA of $6.6 million for the year. The company achieved strong production performance at its Longanesi field, which exceeded expectations and generated $9.1 million in revenue in Q4. AleAnna also secured the…

Siebert Reports 2025 Financial Results

Siebert Reports 2025 Financial Results

Siebert Financial Corp. announced its 2025 financial results, showing a 12% revenue increase driven by a 51% rise in stock loan revenue and growth in retail customer net worth. However, operating income declined due to significant investments in new business lines and technology. The company expanded into collegiate athlete NIL negotiation services…

AirJoule Technologies Announces Fourth Quarter and Full Year 2025 Results and Provides Business Update

AirJoule Technologies Announces Fourth Quarter and Full Year 2025 Results and Provides Business Update

AirJoule Technologies Corporation announced its Q4 and full year 2025 results, highlighting successful technology validation, product development, strategic partnerships with industry leaders and defense, and strengthened financial position. The company confirmed progress in field deployments across multiple geographies and outlined plans to launch…

Intercont (Cayman) Limited Announces Effective Time of Share Consolidation/Reverse Share Split to Regain NASDAQ Compliance

Intercont (Cayman) Limited Announces Effective Time of Share Consolidation/Reverse Share Split to Regain NASDAQ Compliance

Intercont (Cayman) Limited will implement a 25-for-1 reverse share split effective April 2, 2026 to comply with Nasdaq's minimum $1.00 bid price requirement. The company aims to maintain its listing on the Nasdaq Capital Market under ticker symbol NCT, with adjusted shares and a new CUSIP number. The reverse split reduces total authorized shares, a…

JD.com Announces Proposed Offering of CNY-denominated Senior Notes

JD.com Announces Proposed Offering of CNY-denominated Senior Notes

JD.com, Inc., a leading supply chain-based technology and service provider, announced its plan to offer CNY-denominated senior unsecured notes in offshore transactions targeting non-U.S. persons. The proceeds from this offering will be used for general corporate purposes including repayment of existing indebtedness. The notes offering is subject to…

Iperionx – Change of Directors and Officers Ownership

Iperionx – Change of Directors and Officers Ownership

IperionX Limited has reported recent changes in the ownership stakes of its directors and officers, filing the information with both the U.S. Securities and Exchange Commission and the Australian Securities Exchange. Key executives, including the CEO and President, have acquired additional shares and American Depositary Shares, reflecting internal …

Autozi Internet Technology (Global) Ltd. Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities

Autozi Internet Technology (Global) Ltd. Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities

Autozi Internet Technology (Global) Ltd. announced that it received a notification from Nasdaq for failing to meet the minimum Market Value of Listed Securities of $50 million over the past 30 consecutive business days. The company has until September 21, 2026, to regain compliance or face potential delisting. The notification does not impact curre…

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

MoonLake Immunotherapeutics reported Week 40 results from its Phase 3 VELA clinical trials evaluating sonelokimab in adults with moderate-to-severe hidradenitis suppurativa (HS). The data demonstrated continued improvement with 62% of patients achieving HiSCR75 and up to 32% achieving HiSCR100 responses, alongside significant quality of life enhanc…

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Kymera Therapeutics announced positive results from its BroADen Phase 1b trial of KT-621, a novel oral STAT6 degrader, in patients with moderate-to-severe atopic dermatitis. The data showed significant biological and clinical improvements with a favorable safety profile. Ongoing Phase 2b trials in atopic dermatitis and asthma are expected to provid…

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

Arcutis Biotherapeutics announced new positive Phase 2 results from the INTEGUMENT-INFANT trial showing that ZORYVE (roflumilast) cream 0.05% is effective and well tolerated in infants aged 3 months to less than 24 months with mild to moderate atopic dermatitis. Caregivers reported rapid itch improvement and multiple clinical endpoints demonstrated…

Osisko Development Reports Fourth Quarter and Year-End 2025 Results

Osisko Development Reports Fourth Quarter and Year-End 2025 Results

Osisko Development Corp. announced its financial and operational results for Q4 and full-year 2025, highlighting approximately CAD 422.3 million in cash, sales of nearly 4,000 ounces of gold from small-scale activities at the Tintic Project, and significant advancement in the Cariboo Gold Project's infill drilling and pre-construction activities. T…

Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency

Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency

Rocket Lab successfully launched its 85th mission, marking the first dedicated launch for the European Space Agency (ESA) using its Electron launch vehicle. The 'Daughter Of The Stars' mission delivered ESA's Celeste satellites to low Earth orbit to demonstrate enhanced satellite navigation alongside Europe's Galileo constellation. This success und…

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Alumis Inc. reported positive Phase 3 results for envudeucitinib, its oral TYK2 inhibitor, demonstrating robust skin clearance, rapid improvements in quality of life and itch relief, and a favorable safety profile in patients with moderate-to-severe plaque psoriasis. Data from two pivotal trials ONWARD1 and ONWARD2 indicate sustained efficacy throu…

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

Priovant Therapeutics, a Roivant company, reported positive Phase 3 trial results for brepocitinib in dermatomyositis, showing statistically significant improvements over placebo in multiple efficacy endpoints including muscle strength, skin disease, physical function, and corticosteroid reduction. Results were published in the New England Journal …